Legal & General Group’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $958K | Buy |
|
|||||
|
2025
Q2 | $54.2K | Sell |
|
|||||
|
2025
Q1 | $250K | Sell |
|
|||||
|
2024
Q4 | $345K | Buy |
|
|||||
|
2024
Q3 | $322K | Hold |
|
|||||
|
2024
Q2 | $350K | Buy |
|
|||||
|
2024
Q1 | $763K | Buy |
|
|||||
|
2023
Q4 | $60.7K | Sell |
|
|||||
|
2023
Q3 | $21.8K | Buy |
|
|||||
|
2023
Q2 | $22.9K | Hold |
|
|||||
|
2023
Q1 | $7.75K | Hold |
|
|||||
|
2022
Q4 | $9.25K | Hold |
|
|||||
|
2022
Q3 | $21K | Hold |
|
|||||
|
2022
Q2 | $21K | Buy |
|
|||||
|
2022
Q1 | $25K | Buy |
|
|||||
|
2021
Q4 | $21K | Hold |
|
|||||
|
2021
Q3 | $18K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $9K | Sell |
|
|||||
|
2019
Q4 | $19K | Buy |
|
|||||
|
2019
Q3 | $19K | Hold |
|
|||||
|
2019
Q2 | $17K | Buy |
|